114 related articles for article (PubMed ID: 11297813)
1. The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.
Fadel J; Dobner PR; Deutch AY
Neurosci Lett; 2001 Apr; 303(1):17-20. PubMed ID: 11297813
[TBL] [Abstract][Full Text] [Related]
2. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
Brun P; Steinberg R; Le Fur G; Soubrié P
J Neurochem; 1995 May; 64(5):2073-9. PubMed ID: 7722490
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.
Chartoff EH; Ward RP; Dorsa DM
J Pharmacol Exp Ther; 1999 Nov; 291(2):531-7. PubMed ID: 10525068
[TBL] [Abstract][Full Text] [Related]
4. SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum.
Steinberg R; Rodier D; Mons G; Gully D; Le Fur G; Soubrié P
Neuropeptides; 1995 Jul; 29(1):27-31. PubMed ID: 7566510
[TBL] [Abstract][Full Text] [Related]
5. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
6. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
7. SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.
Brouard A; Heaulme M; Leyris R; Pelaprat D; Gully D; Kitabgi P; Le Fur G; Rostene W
Eur J Pharmacol; 1994 Mar; 253(3):289-91. PubMed ID: 8200423
[TBL] [Abstract][Full Text] [Related]
8. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
[TBL] [Abstract][Full Text] [Related]
9. EEDQ reduces the striatal neurotensin mRNA response to haloperidol.
Adams MR; Dobie DJ; Merchant KM; Unis A; Dorsa DM
Peptides; 1997; 18(4):527-35. PubMed ID: 9210171
[TBL] [Abstract][Full Text] [Related]
10. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
Merchant KM
Mol Cell Neurosci; 1994 Aug; 5(4):336-44. PubMed ID: 7804603
[TBL] [Abstract][Full Text] [Related]
11. The neurotensin receptor antagonist SR 48692 decreases extracellular striatal GABA in rats.
Chapman MA; See RE
Brain Res; 1996 Aug; 729(1):124-6. PubMed ID: 8874884
[TBL] [Abstract][Full Text] [Related]
12. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Ward RP; Dorsa DM
Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
[TBL] [Abstract][Full Text] [Related]
13. C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum.
Robertson GS; Tetzlaff W; Bedard A; St-Jean M; Wigle N
Neuroscience; 1995 Jul; 67(2):325-44. PubMed ID: 7675173
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice.
Fadel J; Dobner PR; Deutch AY
Neurosci Lett; 2006 Jul; 402(1-2):97-101. PubMed ID: 16632196
[TBL] [Abstract][Full Text] [Related]
15. Effects of neurotensin receptor antagonists on the firing rate of rat ventral pallidum neurons.
Michaud JC; Gueudet C; Soubrié P
Neuroreport; 2000 May; 11(7):1437-41. PubMed ID: 10841353
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
Merchant KM; Dorsa DM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3447-51. PubMed ID: 8097317
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons.
Hentschel K; Cheung S; Moore KE; Lookingland KJ
Neuroendocrinology; 1998 Aug; 68(2):71-6. PubMed ID: 9705573
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.
Ishibashi T; Ikeda K; Ishida K; Yasui J; Tojima R; Nakamura M; Ohno Y
Eur J Pharmacol; 1996 May; 303(3):247-51. PubMed ID: 8813576
[TBL] [Abstract][Full Text] [Related]
19. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus.
Brog JS; Zahm DS
Neuroscience; 1996 Oct; 74(3):805-12. PubMed ID: 8884776
[TBL] [Abstract][Full Text] [Related]
20. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat.
Zahm DS; Williams ES; Krause JE; Welch MA; Grosu DS
J Comp Neurol; 1998 Nov; 400(4):487-503. PubMed ID: 9786410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
